288318-31-0 Usage
Uses
Used in Pharmaceutical Industry:
(3-methyl-5-isoxazolyl)acetonitrile(SALTDATA: FREE) is used as a building block for the synthesis of various pharmaceuticals. Its chemical structure allows it to be a key component in the development of new drugs, contributing to the advancement of medical treatments.
Used in Agrochemical Industry:
In the agrochemical industry, (3-methyl-5-isoxazolyl)acetonitrile(SALTDATA: FREE) is utilized as a starting material for the creation of novel agrochemicals. Its incorporation in the synthesis process aids in the development of innovative products that can enhance agricultural productivity and crop protection.
Used in Material Science:
(3-methyl-5-isoxazolyl)acetonitrile has been investigated for its potential use in the development of new materials. Its unique properties make it a promising candidate for contributing to the advancement of material science, potentially leading to the creation of improved materials with various applications.
Used as a Neuroprotective Agent:
(3-methyl-5-isoxazolyl)acetonitrile(SALTDATA: FREE) has been studied for its potential biological activities, including its role as a neuroprotective agent. This application is significant as it may contribute to the development of treatments for neurological disorders and conditions.
Used as a Reagent in Organic Synthesis:
Additionally, (3-methyl-5-isoxazolyl)acetonitrile serves as a reagent in organic synthesis. Its chemical properties make it a valuable tool for chemists in the development of new compounds and the improvement of existing synthetic methods.
Check Digit Verification of cas no
The CAS Registry Mumber 288318-31-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,8,8,3,1 and 8 respectively; the second part has 2 digits, 3 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 288318-31:
(8*2)+(7*8)+(6*8)+(5*3)+(4*1)+(3*8)+(2*3)+(1*1)=170
170 % 10 = 0
So 288318-31-0 is a valid CAS Registry Number.
288318-31-0Relevant articles and documents
HETEROCYCLIC COMPOUNDS FOR THE INHIBITION OF PASK
-
, (2014/05/24)
Disclosed herein are new heterocyclic compounds and compositions and their application as pharmaceuticals for the treatment of disease. Methods of inhibiting PAS Kinase (PASK) activity in a human or animal subject are also provided for the treatment of diseases such as diabetes mellitus.
